[1] Zhu JZ, Zhou QY, Wang YM, et al. Prevalence of fatty liver disease and the economy in China: a systematic review.World J Gastroenterol,2015,21: 5695-5706.
[2] Newton JL, Jones DE, Henderson E,et al. Fatigue in non-alcoholic fatty liver disease(NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut,2008,57:807-813.
[3] van Steenbergen-Weijenburg KM, de Vroege L, Ploeger RR,et al. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Serv Res,2010,10:235.
[4] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.中国非酒精性脂肪性肝病诊疗指南(2010年修订版).中国医学前沿杂志(电子版),2012,4:4-10.
[5] Weinstein AA, Kallman Price J, Stepanova M etal.Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis Band C.Psychosomatics,2011,52:127-132.
[6] Fujii H, Kawada N. Inflammation and fibrogenesis in steatohepatitis. J Gastroenterol,2012,47: 215-225.
[7] Dantzer R, O’Connor JC, Lawson MA, et al.Inflammation-associated depression: from serotonin to kynurenine. Psych-oneuroendocrinology,2011, 36: 426-436.
[8] Herrera-Marquez R, Hernandez-Rodriguez J,et al. Association of metabolic syndrome with reduced central serotonergic activity.Metab Brain Dis,2011, 26:29-35.
[9] Taylor VH, Macqueen GM.The role of adipokines in under-standing the associations between obesity and depression. J Obes,2010;2010. pii: 748048. |
